Clinical evaluation of injection azithromycin in the treatment of the acute bacteria pneumonia of infant
- VernacularTitle:阿奇霉素治疗婴幼儿细菌性肺炎临床观察
- Author:
Yuhong DONG
;
Yingfin SHI
;
Liping YAO
;
Guiqing WANG
- Publication Type:Journal Article
- Keywords:
Pneumonia,mycoplasma;
Azithromgcin;
Erythromycin;
Child
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(10):1617-1618
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical efficacy and safety of injection azithromycin in the treatment of the acute bacteria pneumonia of infant. Methods A randomized controlled open trial was carried out. Erythromycin as a controll drug was compared the clinical efficacy and safety with azithromycin as a test drug. Results In azithro-mycin group,the clinical effective rate was 90.6% ;the fully recovered rate was 75.5%. While those of erythromycin group were 68.0% ,36.0% respectively. The incidence of adverse reaction was 9.3% and 30.4% respectively in two groups. Conclusion Injection azithromycin of new macrofides type is a kind of effective and safe anti-bacterial drug.
